Rapid cardiac troponin I test RAMP®

for cardiovascular diseasesbloodimmunochromatographic

The definitive biomarker for acute myocardial infarction (AMI) Estimated 17.9 million people died from cardiovascular diseases in 2016, representing 31% of all global deaths There are 32.4 million myocardial infarctions and strokes worldwide every year The sensitivity of ECGs for MI is poor (28%-54%) One-thirds of MI patients do not present with chest pain but instead with non-specific symptoms such as fatigue, nausea, dizziness WHEN EARLY RECOGNITION OF AMI IS KEY Estimated 17.9 million people died from cardiovascular diseases in 2016, representing 31% of all global deaths There are 32.4 million myocardial infarctions and strokes worldwide every year The sensitivity of ECGs for MI is poor (28%-54%) One-thirds of MI patients do not present with chest pain but instead with non-specific symptoms such as fatigue, nausea, dizziness Cardiac Troponin is the gold standard test for myocardial infarction and is usually the first test ordered for patients with chest pain Measurements of cardiac troponin I can improve diagnosis and treatment of myocardial infarction (MI) With RAMP Troponin I, healthcare professionals can obtain a quantitative measurement of cardiac troponin I from 75uL of blood without the need for centrifugation RAMP tests are individual, single-use quantitative tests that provide rapid, accurate, lab quality results within minutes